With a market cap of $30.1 billion, DuPont de Nemours, Inc. (DD) is a global leader in technology-based materials, ingredients, and solutions, serving diverse markets such as electronics, transportation, construction, health and wellness, food, and worker safety. It operates through ElectronicsCo and IndustrialsCo, offering innovative products across diversified markets worldwide.

Shares of the Wilmington, Delaware-based company have underperformed the broader market over the past 52 weeks. DD stock has declined 8.2% over this time frame, while the broader S&P 500 Index ($SPX) has gained 20.6%. Moreover, shares of DuPont have dipped 5.7% on a YTD basis, compared to SPX's 9.6% return.

Looking closer, the specialty chemicals maker stock has also lagged behind the Materials Select Sector SPDR Fund's (XLB) 1.3% rise over the past 52 weeks.

Shares of DuPont rose 2.4% on Aug. 5 after the company reported Q2 2025 adjusted EPS of $1.12 and revenue of $3.3 billion, topping forecasts. Strong demand in its electronics segment, with sales rising to $1.2 billion, and healthcare growth helped offset weakness in construction markets. DuPont also issued Q3 guidance above expectations, forecasting $1.15 per share in profit and $3.3 billion in revenue, while lowering its expected 2025 tariff hit to $20 million.

For the fiscal year ending in December 2025, analysts expect DD's EPS to grow 7.9% year-over-year to $4.39. The company's earnings surprise history is promising. It beat the consensus estimates in the last four quarters. 

Among the 17 analysts covering the stock, the consensus rating is a “Strong Buy.” That’s based on 12 “Strong Buy” ratings, one “Moderate Buy,” and four “Holds.”

On Aug. 7, BMO Capital’s John McNulty maintained a “Buy" rating on DuPont de Nemours, setting a price target of $101 - the Street-high price target. This implies a potential upside of 40.4% from the current price levels.

As of writing, the stock is trading below the mean price target of $88.19.